The World Congress on Precision Medicine and Genomic Healthcare (Precision Med 2027) is a premier international event dedicated to advancing precision medicine, genomics, and personalized healthcare through scientific innovation, interdisciplinary collaboration, and clinical excellence. Scheduled for March 08–10, 2027, in Singapore, this hybrid congress offers participants the flexibility to attend in person or virtually, bringing together leading researchers, clinicians, geneticists, molecular biologists, bioinformaticians, healthcare professionals, pharmaceutical experts, industry leaders, and policymakers from around the world.
Theme: Unlocking the Potential of Genomics to Transform Precision Healthcare
The conference features an engaging scientific program comprising keynote addresses by internationally renowned experts, plenary lectures, panel discussions, oral and poster presentations, young researcher sessions, workshops, and networking events. These sessions are designed to foster collaboration between academic institutions, healthcare organizations, biotechnology companies, pharmaceutical industries, diagnostic laboratories, and research centers while encouraging the translation of scientific discoveries into real-world clinical applications.
Join us in Singapore or participate online to be part of this transformative global gathering and contribute to advancing the next generation of precision medicine and genomic healthcare.
Precision Medicine and Personalized Healthcare are revolutionizing modern healthcare by replacing generalized treatment approaches with individualized care based on a patient's genetic profile, lifestyle, environmental factors, and clinical history. Advances in genomic medicine, molecular diagnostics, pharmacogenomics, and artificial intelligence enable healthcare providers to deliver more accurate diagnoses, targeted therapies, and preventive interventions. This patient-centered approach improves treatment effectiveness, minimizes adverse drug reactions, and supports better long-term health outcomes across a wide range of medical specialties, including oncology, cardiology, neurology, and rare genetic disorders.
This scientific session will highlight the latest developments in precision medicine, biomarker discovery, personalized therapeutics, and data-driven clinical decision-making. It will provide a platform for researchers, clinicians, geneticists, bioinformaticians, and healthcare innovators to discuss emerging technologies, translational research, and real-world clinical applications. Participants will explore how personalized healthcare is transforming disease prevention, diagnosis, and treatment while addressing the ethical, regulatory, and implementation challenges of integrating precision medicine into routine clinical practice.
Human Genomics has become a driving force in modern biomedical research, enabling a deeper understanding of the genetic basis of health and disease. Rapid advancements in genome sequencing, next-generation sequencing (NGS), genome-wide association studies (GWAS), and bioinformatics have transformed the diagnosis, prevention, and treatment of complex disorders. These innovations are improving the identification of disease-causing variants, supporting early detection, and paving the way for personalized therapeutic strategies. Human genomics is now integral to precision medicine, rare disease diagnosis, cancer genomics, reproductive health, and population health research.
This scientific session will explore the latest breakthroughs in human genomics, genomic technologies, functional genomics, and their clinical applications. It will bring together geneticists, clinicians, molecular biologists, bioinformaticians, researchers, and healthcare professionals to discuss emerging discoveries, translational research, and innovative genomic tools. Participants will gain insights into the role of genomics in disease prediction, therapeutic development, and precision healthcare while addressing ethical, legal, and societal challenges associated with genomic data and genetic testing.
AI-Powered Precision Medicine is transforming healthcare by combining artificial intelligence, machine learning, and advanced data analytics with genomic, clinical, and imaging data to deliver highly personalized patient care. AI-driven algorithms can identify disease patterns, predict treatment responses, and support early diagnosis with greater speed and accuracy than traditional methods. These technologies are enhancing clinical decision-making, optimizing targeted therapies, improving patient outcomes, and accelerating drug discovery across fields such as oncology, cardiology, neurology, and rare diseases.
This scientific session will showcase the latest innovations in AI-powered precision medicine, focusing on intelligent diagnostics, predictive analytics, precision therapeutics, and digital health solutions. Experts from medicine, data science, bioinformatics, genomics, and healthcare technology will discuss cutting-edge research, real-world clinical applications, and the challenges of integrating AI into routine healthcare. Participants will gain insights into how AI is reshaping personalized medicine while addressing data privacy, algorithm transparency, regulatory frameworks, and ethical considerations for future clinical practice.
Multi-Omics Integration and Systems Biology are transforming biomedical research by combining data from genomics, transcriptomics, proteomics, metabolomics, and epigenomics to provide a comprehensive understanding of biological systems and disease mechanisms. By integrating diverse molecular datasets with advanced computational modeling, bioinformatics, and artificial intelligence, researchers can uncover complex biological networks, identify novel biomarkers, and accelerate the development of precision medicine strategies. These approaches are advancing disease diagnosis, therapeutic target discovery, drug development, and personalized treatment across oncology, neurology, cardiovascular diseases, metabolic disorders, and infectious diseases.
This scientific session will highlight the latest advances in multi-omics technologies, systems biology, computational biology, and translational medicine. It will bring together researchers, clinicians, bioinformaticians, computational biologists, and healthcare innovators to discuss data integration methods, network biology, predictive modeling, and clinical applications of multi-omics research. Participants will gain insights into how integrated molecular profiling is enabling precision diagnostics, personalized therapeutics, and improved patient outcomes while addressing challenges related to big data analytics, interoperability, and clinical implementation.
Single-Cell Sequencing and Spatial Biology are revolutionizing biomedical research by enabling scientists to analyze individual cells and their spatial organization within tissues. Unlike conventional bulk sequencing, single-cell sequencing uncovers cellular heterogeneity, gene expression patterns, and molecular interactions at unprecedented resolution. Combined with spatial transcriptomics and advanced imaging technologies, these approaches provide valuable insights into tissue architecture, cell-to-cell communication, disease progression, and therapeutic response. They are driving breakthroughs in precision medicine, cancer research, immunology, neuroscience, developmental biology, and regenerative medicine.
This scientific session will focus on the latest innovations in single-cell genomics, spatial omics technologies, computational biology, and translational medicine. Researchers, clinicians, molecular biologists, and bioinformaticians will discuss emerging sequencing platforms, spatial data integration, biomarker discovery, and clinical applications that enhance disease diagnosis and personalized treatment. The session will also address challenges in data analysis, scalability, and clinical implementation while exploring future opportunities for integrating single-cell and spatial biology into next-generation healthcare.
Precision Oncology and Cancer Genomics are transforming cancer care by leveraging genomic profiling, molecular diagnostics, and biomarker-driven therapies to deliver personalized treatment strategies. Advances in next-generation sequencing (NGS), liquid biopsy, and comprehensive tumor profiling enable clinicians to identify genetic mutations, predict therapeutic responses, and select targeted treatments tailored to individual patients. These innovations are improving early cancer detection, enhancing treatment efficacy, reducing adverse effects, and supporting better clinical outcomes across a wide range of solid tumors and hematologic malignancies.
This scientific session will explore the latest developments in precision oncology, cancer genomics, and translational cancer research. It will bring together oncologists, geneticists, molecular biologists, pathologists, bioinformaticians, and pharmaceutical researchers to discuss emerging genomic technologies, targeted therapies, immunogenomics, and AI-driven cancer diagnostics. Participants will gain insights into biomarker discovery, personalized cancer treatment, and clinical implementation while addressing challenges related to genomic data interpretation, resistance mechanisms, and equitable access to precision cancer care.
Liquid Biopsy is emerging as a groundbreaking, minimally invasive technology for the early detection of cancer, disease monitoring, and personalized treatment selection. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, cell-free DNA (cfDNA), and other blood-based biomarkers, liquid biopsy enables clinicians to identify genetic alterations without the need for invasive tissue biopsies. This innovative approach supports early diagnosis, real-time monitoring of tumor evolution, detection of minimal residual disease, and assessment of treatment response, significantly improving patient outcomes and advancing precision oncology.
This scientific session will highlight recent advances in liquid biopsy, molecular diagnostics, and cancer biomarker research. Experts in oncology, molecular pathology, genomics, laboratory medicine, and translational research will discuss cutting-edge technologies, clinical validation, AI-assisted biomarker analysis, and emerging applications across multiple cancer types. Participants will explore how liquid biopsy is transforming cancer screening, personalized therapy, and disease surveillance while addressing challenges related to analytical accuracy, regulatory standards, and clinical implementation.
Radiomics, Radiogenomics, and Precision Imaging are reshaping modern diagnostics by integrating advanced medical imaging with artificial intelligence, genomic profiling, and quantitative image analysis. Radiomics extracts high-dimensional imaging features from CT, MRI, PET, and ultrasound scans to identify disease characteristics that may not be visible to the human eye. Radiogenomics further links these imaging biomarkers with genetic and molecular profiles, enabling non-invasive disease characterization, improved risk assessment, and personalized treatment planning. These technologies are playing a pivotal role in precision oncology, neurology, cardiology, and other clinical specialties.
This scientific session will explore the latest advances in precision imaging, AI-powered image analysis, radiogenomics, and imaging biomarkers. Researchers, radiologists, oncologists, medical physicists, and bioinformaticians will discuss innovative imaging technologies, machine learning applications, clinical validation, and translational research. Participants will gain insights into how imaging-driven precision medicine is improving disease diagnosis, treatment response prediction, and patient management while addressing challenges in data standardization, interoperability, and clinical adoption.
Iris Scientific Group takes great pride in announcing the successful outcome of the World Health Care and Nursing Conference (WHCN 2019) which was held in Valencia, Spain from September 23-25, 2019.
For WHCN 2019 Final Program: Click here
For WHCN 2019 Proceedings: Click Here
For WHCN 2019 Gallery: Click Here
In 2019 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.
Organizing Committee of WHCN 2019:
The Organizing Committee would like to thank the moderators Angela O'Connor, King Edward Memorial Hospital, Australia, and Carrinna A. Hansen, University of Copenhagen, Denmark for their contribution which ensued in the smooth functioning of the conference.
Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.
Nursing Conference 2019 Keynote Speakers:
Nursing Conference Speakers:
Nursing Conference 2019 Workshops:
Cynthia Horton, Cecil College, USA
Merita Kaunisto, Kuopio University Hospital, Finland
Hanna-Mari Nevala, Savonia University of Applied Sciences, Finland
Tiina Arpola, Savonia University of Applied Sciences, Finland
Nursing Conference 2019 Poster Presenters:
We congratulate the Best poster award winner Chantira Chiaranai, Suranaree University of Technology, Thailand. We would also like to thank Cynthia Horton, Cecil College, USA who supported us by evaluating the posters.
We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.
We greatly hope to see you again, with added vigor and with your other colleagues in "3rd International Nursing Networking Conference (INNC-2025)" during April 23-25, 2025, at Las Vegas, USA, and in Virtual format.
Iris Scientific Group takes great pride in announcing the successful outcome of the World Catalysis and Chemical Engineering Network Congress (WCCN 2025) which was held in Virtual Mode from April 23-25, 2025.
For WCCN 2025 Final Program: Click Here
In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.
Organizing Committee of WCCN 2025:
The Organizing Committee would like to thank the moderators Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina and Rahul Hajare, Sandip University, India for their contribution which ensued in the smooth functioning of the conference.
Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.
WCCN 2025 Keynote Speakers:
WCCN 2025 Plenary Speakers:
WCCN 2025 Speakers:
We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.
We greatly hope to see you again, with added vigor and with your other colleagues in “2nd World Catalysis and Chemical Engineering Network Congress (WCCN 2026)” during April 22-24, 2026. WCCN 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.
Iris Scientific Group takes great pride in announcing the successful outcome of the 3rd International Nursing Networking Conference (INNC 2025) which was held in Virtual Mode from April 23-25, 2025.
For INNC 2025 Final Program: Click Here
In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.
Organizing Committee of INNC 2025:
The Organizing Committee would like to thank the moderators Sofica Bistriceanu, Academic Medical Unit - CMI, Romania, and Anum Fatima, Chiang Mai University, Thailand for their contribution which ensued in the smooth functioning of the conference.
Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.
INNC 2025 Keynote Speakers:
INNC 2025 Speakers:
INNC 2025 Poster Presenters:
We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.
We greatly hope to see you again, with added vigor and with your other colleagues in “4th International Nursing Networking Conference (INNC 2026)” during April 13-15, 2026. INNC 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.
Iris Scientific Group takes great pride in announcing the successful outcome of the International Cancer Conference (ICC 2025) which was held in Virtual Mode from November 27-29, 2025.
For ICC 2025 Final Program: Click Here
In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.
Organizing Committee of ICC 2025:
The Organizing Committee would like to thank the moderators Don Mathew, Pacific Medical College & Hospital, India for his contribution which ensued in the smooth functioning of the conference.
Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.
ICC 2025 Keynote Speakers:
ICC 2025 Speakers:
We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.
We greatly hope to see you again, with added vigor and with your other colleagues in “2nd Edition of International Cancer Conference (ICC 2026)” during November 09-11, 2026. ICC 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.
Iris Scientific Group takes great pride in announcing the successful outcome of the Global Conference on Material Science and Nanotechnology (GCMN 2025) which was held in Virtual Mode from April 28-30, 2025.
For GCMN 2025 Final Program: Click Here
In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.
Organizing Committee of GCMN 2025:
The Organizing Committee would like to thank the moderators Santoshi Misra, St. Ann's College for women, India for her contribution which ensued in the smooth functioning of the conference.
Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.
GCMN 2025 Keynote Speakers:
GCMN 2025 Plenary Speakers:
GCMN 2025 Speakers:
GCMN 2025 Poster Presenters:
We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.
We greatly hope to see you again, with added vigor and with your other colleagues in “2nd Global Conference on Material Science and Nanotechnology (GCMN 2026)” during April 13-15, 2026.
GCMN 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.
Thank YOU! For a wonderful experience. I met so many amazing people from all over the world and many of us bonded going forward. All the presentations were full of new and exciting things to hear and the hotel was just lovely. I enjoyed every minute.
I met some extraordinary nurses from all over and was so impressed with their work
Such a distinguished conference and the entire magnificent organization
Overall, the Conference was a success. Interesting topics and excellent speakers
Thank you very much for a nice and interesting conference in Valencia, I really enjoyed it!
The conference added value to me on medical robots as I would like to apply them to Zambia.
An amazing scientifically enriching continued professional development meaningful experience with a brilliant platform for dynamic collaborations with interactive discussions and expert opinion-insights offering fascinating translational/public health avenues for evidence-based novel immunotherapy regimens and eventual design of predictive biomarkers for cost-effective disease management of inflammatory diseases with emphasis on evidence-based health management viz. gynecologic disorders/diseases in women of diverse genetic landscapes and lifestyles.
The INNC platform provides information from various fields in healthcare for nurses, researchers, educators, administrators, policymakers, and students to improve their knowledge and experiences. In this new digital era, exchanging information in a real and virtual community promises to be a more efficient and attractive way to enrich our lives, foster meaningful relationships, and build a comprehensive and informative database for a better inner world and existence. Participation in these events gratifies people with credentials, recognizing their involvement in learning and contribution to science advancement.
Dear colleagues, thank you for the honor and opportunity to participate in the conference! As always, the geography of the participants, the diversity of topics, and the breadth of interests are pleasing. Various aspects related to nursing, teaching methods, and preventive medicine were important. Such a broad exchange of opinions serves mutual enrichment, deepening mutual understanding, and international cooperation. I wish you further success and prosperity!
Thank you for allowing me to participate in the conference. It was indeed an honor to share information with colleagues from around the world in a virtual setting. By using this technology platform, we are able to become more engaged and immersed in clinical research which truly can make an impact on future clinical practice. I am looking forward to the next INCC conference where knowledge is exchanged and shared.
It was my first participation on an international conference. It was a very valuable and exciting experience for me. The special thing was to understand the different participants because of their mother tongue. My greatest fear was not to be able to understand the others, an other doubt was the insufficiency of my english. so, my advice for every new participant is not to be too nervous, because this event is great and connects us! It would be great to stay in touch.
Wish you all the best and hope to hear from you!!
International Nursing Networking Conference (INNC) 2025. Attending INNC 2025 was an incredible experience. I connected with passionate professionals from around the world, gained valuable insights, and left feeling truly inspired. The sessions were impactful, the networking was genuine, and it reminded me why I chose nursing in the first place. I'm grateful for the opportunity and highly recommend it to anyone in the field.
I had the honor of participating with you in your major scientific conference. I hope you will share the conference documents with me. Thank you for the opportunity. I am currently developing a detailed protocol on the role and policies of nursing during disasters and catastrophes, including the role of nursing in nuclear disasters. I hope to have future scientific meetings to share and develop science.
Great greetings, Thanks a lot for your great efforts & unlimited care. It was a great & valuable conference. All presentations were fruitful. Looking for more future collaboration.
I sincerely appreciate the privilege to be part of the participants at GCMN 2025. The conference was indeed an eye opener to the advancements in Material Science in various continents of the earth. The conference was really a success. Special thanks to the organizers of the academic conference for their hard work and support given to all participants before, during and after the scheduled conference activities.